In a judgment that wasn’t accompanied by any opinion, the U.S. Court of Appeals for the Federal Circuit recently affirmed without comment a 2013 ruling from a Delaware federal district court that allowed Lupin Pharmaceuticals Inc. to launch a generic version of ViiV Healthcare’s AIDS treatment Trizivir (VIIV Healthcare UK, Ltd. v. Lupin, Ltd.).
The Federal Circuit, in an unsigned opinion, affirmed the lower court’s ruling that Lupin’s generic wouldn’t infringe a patent covering the drug 12 PLIR 7, 1/3/14.
In December 2013, Judge Richard G. Andrews of the U.S. District Court for the District of Delaware ...
Learn more about Bloomberg Law or Log In to keep reading:
See Breaking News in Context
Bloomberg Law provides trusted coverage of current events enhanced with legal analysis.
Already a subscriber?
Log in to keep reading or access research tools and resources.